Skip to main content
Natural Products and Bioprospecting logoLink to Natural Products and Bioprospecting
. 2016 Sep 21;6(5):261–265. doi: 10.1007/s13659-016-0106-6

Furoquinoline Alkaloids and Methoxyflavones from the Stem Bark of Melicope madagascariensis (Baker) T.G. Hartley

Vincent E Rasamison 1, Peggy J Brodie 2, Emilio F Merino 3, Maria B Cassera 3, Michel A Ratsimbason 1, Stephan Rakotonandrasana 1, Andriamalala Rakotondrafara 1, Elie Rafidinarivo 4, David G I Kingston 2, Harinantenaina L Rakotondraibe 5,
PMCID: PMC5080208  PMID: 27655634

Abstract

Abstract

Melicope madagascariensis (Rutaceae) is an endemic plant species of Madagascar that was first classified as a member of the genus Euodia J. R. & G. Forst (Rutaceae) under the scientific name Euodia madagascariensis Baker. Based on morphological characteristics, Thomas Gordon Hartley taxonomically revised E. madagascariensis Baker to be M. madagascariensis (Baker) T.G. Hartley. Chemotaxonomical studies have long been used to help the identification and confirmation of taxonomical classification of plant species and botanicals. Aiming to find more evidences to support the taxonomical revision performed on E. madagascariensis, we carried out phytochemical investigation of two samples of the plant. Fractionation of the ethanol extracts prepared from two stem bark samples of M. madagascariensis (Baker) T.G. Hartley led to the isolation of seven known furoquinoline alkaloids 17 and two known methoxyflavones 8 and 9. The presence of furoquinoline alkaloids and methoxyflavones in the title species is in agreement with its taxonomic transfer from Euodia to Melicope. Antiprotozoal evaluation of the isolated compounds showed that 6-methoxy-7-hydroxydictamnine (heliparvifoline, 3) showed weak antimalarial activity (IC50 = 35 µM) against the chloroquine-resistant strain Dd2 of Plasmodium falciparum. Skimmianine (4) displayed moderate cytotoxicity with IC50 value of 1.5 µM against HT-29 colon cancer cell line whereas 3,5-dihydroxy-3′,4′,7-trimethoxyflavone (9) was weakly active in the same assay (IC50 = 13.9 µM).

Graphical Abstract

graphic file with name 13659_2016_106_Figa_HTML.jpg

Keywords: Chemotaxonomy, Furoquinoline alkaloids, Methoxyflavones, Antimalarial activity, Cytotoxicity, Melicope madagascariensis (Rutaceae)

Introduction

The genus Melicope J. R. & G. Forst (Rutaceae) comprises about 235 species distributed in the Madagascar and Mascarenes islands and Indo-Himalaya regions in the Hawaii and Marquesas islands to New Zealand. Melicope madagascariensis (Baker) T.G. Hartley is an endemic species to Madagascar, which has long been classified in the genus Euodia J. R. & G. Forst (Rutaceae) under the scientific name Euodia madagascariensis Baker before being assigned to the genus Melicope. This taxonomic revision introduced by Hartley in 2001 was based on morphological characteristics and concerned the other Madagascan plant species that were placed in the genus Euodia [1].

M. madagascariensis is a tree up to 10–20 m tall which is encountered in the rainforest of Madagascar and is traditionally employed as exhilarating agent, purgative, and in formulations for the treatment of liver, kidney and stomach disorders, bronchitis and mumps [2]. Members of the genus Melicope are rich sources of furoquinoline alkaloids, methoxyflavones and acetophenones, some of which have elicited antiplatelet aggregation [3], cytotoxic [4] and antimalarial activities [5]. A previous phytochemical study on M. madagascariensis reported the isolation of methoxyflavones [6], a class of compounds that have also been found in Euodia species already transferred into Melicope. As part of our ongoing projects aiming to characterize secondary metabolites of plants originated from Madagascar rainforest for biological and chemotaxonomical studies, we carried out phytochemical investigation of M. madagascariensis, which is one of the eleven Melicope species endemic to Madagascar. This paper deals with the isolation of nine known compounds including seven furoquinoline alkaloids 17 and two methoxyflavones 8 and 9 from two samples of the stem bark of this species. Herein, we discuss the chemotaxonomic significance as well as the antimalarial and cytotoxic activities of the isolated compounds.

Results and Discussion

A stem bark sample of M. madagascariensis was collected from Zahamena, Madagascar. Its ethanol extract (MG250) was first subjected to a modified Kupchan partitioning to give hexane-soluble, chloroform (CHCl3)-soluble and aqueous MeOH-soluble extracts. Fractionation of the CHCl3-soluble extract by successive open column chromatography over Sephadex LH-20 and silica gel yielded three furoquinoline alkaloids, pteleine (1) [7], evolitrine (2) [7] and 6-methoxy-7-hydroxydictamnine (heliparvifoline, 3) [8].

Further phytochemical investigation of the same plant was conducted on a larger collection of stem bark (ST1375) samples collected from Moramanga, Madagascar. Fractionation of the ethanol extract of ST1375 was first carried out by performing selective isolation of alkaloids through conventional acid–base treatment of the CHCl3-soluble extract obtained from the same method as above, to finally provide basic and neutral fractions. Subsequent separations of these two fractions by a combination of chromatography techniques (Column Chromatography, HPLC and preparative TLC) yielded four furoquinoline alkaloids identified as: skimmianine (4) [9], confusameline (5) [10], dictamnine (6) [7] and 7,8-dimethoxyplatydesmine (7) [11], and two methoxyflavones, kumatakenin (8) [12] and 3,5-dihydroxy-3′,4′,7-trimethoxyflavone (9) [12]. This is the first report of the isolation of compounds 19 (Fig. 1) from M. madagascariensis. Except the 3,5-dihydroxy-3′,4′,7-trimethoxyflavone (9), all the other compounds isolated in the present work have been already encountered in other Melicope species, such as M. semecarpifolia and M. pteleifolia [3, 13].

Fig. 1.

Fig. 1

Structures of compounds 113

With the exception of few species including those of the genus Euodia, furoquinoline alkaloids are widespread in the Rutaceae family [14]. In particular, a number of furoquinoline alkaloids and derivatives have been reported from species of the genus Melicope [3, 15, 16]. The isolation of furoquinoline alkaloids from M. madagascariensis chemotaxonomically confirmed the classification of the present plant species in the genus Melicope of the Rutaceae family. Furthermore, polyoxygenated flavones (polymethoxy and methylenedioxy) have been considered to be characteristic chemical components of plant species of the genus Melicope inside the Rutaceae family [17]. The isolation of furoquinoline alkaloids and methoxylated flavones from the present plant species is in good agreement with its taxonomic reassignment from Euodia into Melicope. This study added one more species to the Melicope-producing methoxyflavones. Whether all of the Euodia species containing furoquinoline alkaloids and methoxyflavones should be moved to the genus Melicope or not is one of the major questions that can be unfolded from the present investigation. Apart from the morphological and phytochemical contributions, full genome sequencing of all species of the genus to be transferred would complete this taxonomical classification.

The sample MG250 was collected for the International Cooperative Biodiversity Group (ICBG)/Madagascar program that was mainly aimed at searching for antimalarial and antiproliferative agents from natural resources from Madagascar. Evaluation of compounds 13 for their antimalarial activity against the multidrug-resistant strain Dd2 of Plasmodium falciparum showed that only heliparvifoline (3) exhibited growth inhibitory effect at relatively high concentration (IC50 = 35 µM). Positive control consisted of fosmidomycin (IC50 = 0.31 µM). Moreover, in vitro antimalarial activity against the chloroquine-susceptible HB3 (Honduras) and the chloroquine resistant W-2 (Indochina) strains of P. falciparum has been previously performed on some Rutaceous furoquinoline alkaloids such as skimmianine (4), haplopine (10), kokusaginine (11), acronycidine (12) and acronydine (13) [18]. Although the compounds isolated in the present study did not exhibit strong antimalarial activity against the multidrug-resistant strain Dd2 of Plasmodium falciparum, the present paper added more data on the antimalarial activity of furoquinoline alkaloids of Rutaceous plants. In addition, compounds 49 isolated from the sample ST1375 were assayed against the human colorectal adenocarcinoma (HT-29) cell line. As results, compounds 58 were inactive in this assay while skimmianine (4) and 3,5-dihydroxy-3′,4′,7-trimethoxyflavone (9) exhibited moderate and weak activity with IC50 values of 1.5 µM and 13.9 µM, respectively.

Conclusions

The current study extends the knowledge about the chemistry of M. madagascariensis. The presence of furoquinoline alkaloids and methoxylated flavones in this plant provides support to its re-classification from the genus Euodia to Melicope. Heliparvifoline (3) displayed weak antimalarial activity (IC50 = 35 μM) against strain Dd2 of P. falciparum whereas skimmianine (4) and 3,5-dihydroxy-3′,4′,7-trimethoxyflavone (9) were identified as the most cytotoxic constituents against HT-29 colon cancer line.

Experimental Section

General Experimental Procedures

1H NMR spectra were recorded on Bruker Avance 400 and 500 spectrometers in CDCl3 or CD3OD with TMS as internal standard. Semi-preparative HPLC was performed on a Shimadzu instrument consisting of LC-20AB pump, SPD-20A Prominence detector and CBM–20Alite system controller. Sephadex LH-20 (Sigma), silica gel 60 (EMD Chemicals, 0.04–0.063 mm) and C18 reversed phase silica gel (EMD Chemicals, 0.04–0.063 mm) were used for column chromatography.

Antimalarial Assay

The antimalarial assay was carried out at Virginia Tech against the multidrug-resistant strain Dd2 of P. falciparum by using the SYBR Green I-based plate assay as previously reported [19].

Cytotoxicity Assay

Cytotoxicity assay against HT-29 human colon cancer cell line was performed at the College of Pharmacy, The Ohio State University, USA by using a sulforhodamine B reduction assay procedure as described in a previous paper [20].

Plant Material

The first sample coded MG250 of M. madagascariensis stem bark was collected in February 2000 from plants growing in the forest adjacent to the Zahamena National Park. A larger collection of the same plant material designated ST1375 was conducted in November 2009 in the Antsasaka forest of Moramanga. These two collection sites were about 250 km distant from each other in the Atsinanana region of Madagascar. Voucher specimens have been deposited at the herbarium of the Centre National d’Application de Recherches Pharmaceutiques (CNARP), Antananarivo, Madagascar under the codes RJO157 for MG250 and ST1375 B for ST1375.

Extraction and Isolation

The dried and powdered sample MG250 (300 g) was macerated in EtOH for 48 h to yield 11.5 g of a crude EtOH extract. A portion (1.5 g) was suspended in 90 % aqueous MeOH (150 mL) and extracted with n-hexane (3 × 200 mL portions). The aqueous MeOH layer was then diluted to 60 % aqueous MeOH by addition of water before partitioning with CHCl3 (3 × 200 mL portions). Finally, the aqueous MeOH phase was vacuum concentrated, suspended in H2O (75 mL) and extracted with n-BuOH saturated with water (3 × 75 mL portions). Elimination of all the solvents in vacuo provided dried n-hexane soluble fraction (143.5 mg), CHCl3-soluble fraction (538.6 mg), n-BuOH-soluble fraction (131 mg) and H2O-soluble fraction (630.8 mg). The CHCl3-soluble fraction was chromatographed over Sephadex LH-20 column eluted with CH2Cl2/MeOH, 1:1 and then silica gel column eluted with n-hexane/EtOAc, 7:3 to give compounds 1 (0.9 mg), 2 (0.8 mg) and 3 (1.2 mg).

The dried and powdered sample ST1375 (1.3 kg) was extracted as above to afford a crude EtOH extract (65.3 g). A portion (25 g) was liquid–liquid partitioned using same procedures described above. The resulting CHCl3 fraction was subjected to a conventional acid–base extraction to afford a basic CHCl3-soluble fraction (Fraction A, 343.7 mg) and a neutral CHCl3-soluble fraction (Fraction B, 11.2 g). Fraction A was first gel filtered on a Sephadex LH-20 column eluted with n-hexane/CH2Cl2/MeOH, 4:3:3 to give four pooled fractions (A1-A4). Fraction A2 was subjected to a combination of silica gel open column chromatography and HPLC on a semi-preparative C18 column (Purospher column, 5 µm, 25 × 1 cm) or silica gel preparative TLC to furnish 4 (1.4 mg) and 7 (0.9 mg). Fraction A4 (191.4 mg) was rechromatographed over silica gel open column eluted with n-hexane/EtOAc mixtures to give 5 (3.1 mg). A part of the fraction B (4 g) was flash chromatographed on silica gel column to furnish six subfractions (B1-B6). Subfraction B2 (171.5 mg) was separated by C18 open column chromatography and then by silica gel preparative TLC with CHCl3/MeOH, 50:1 as eluent to furnish 8 (3.4 mg), 9 (2.7 mg) and 6 (1.4 mg).

Structures of isolated compounds were established by the interpretation of their 1H NMR spectra and comparison of data obtained with those published in the literature. The 1H NMR spectroscopic data of the isolated compounds can be obtained free of charge from the corresponding author.

Acknowledgments

The authors are thankful to the ICBG project (Grant No U01 TW000313) and the CNARP for financial support during the plant collections and the supply of chemicals critical to this study. Thanks are also due to the College of Pharmacy at The Ohio State University, USA and the Department of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, USA for facilitating the acquisition of the NMR spectra.

Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflict interest.

Footnotes

The botanical collection in Madagascar was carried out under a benefit-sharing agreement between all the parties involved, and under the authority of plant collection and extract export permits issued by the government of Madagascar.

References

  • 1.Hartley TG. Allertonia. 2001;8:1–341. [Google Scholar]
  • 2.E.N. Matu, Melicope madagascariensis (Baker) T.G. Hartley, ed. by G.H. Schmelzer and A. Gurib-Fakim. Prota11 (2): Medicinal Plants 2. PROTA, (Wageningen, Netherlands, 2013), p 193
  • 3.Chen IS, Chen HF, Cheng M-J, Chang YL, Teng CM, Tsutomu I, Chen JJ, Tsai IL. J. Nat. Prod. 2001;64:1143–1147. doi: 10.1021/np010122k. [DOI] [PubMed] [Google Scholar]
  • 4.Rei-Sheu H, Chano-Yih D, Shang-Kwei W, Tai-Tsung C. Phytochemistry. 1993;35:271–272. doi: 10.1016/S0031-9422(00)90550-8. [DOI] [Google Scholar]
  • 5.Simonsen HT. Phytochem. Lett. 2012;5:371–375. doi: 10.1016/j.phytol.2012.03.005. [DOI] [Google Scholar]
  • 6.Gleye J, Moulis C, Doazan MN. Plant. Med. Phytother. 1983;17:92–95. [Google Scholar]
  • 7.Pusset J, Lopez JL, Pais M, Neirabeyeh MA, Veillon JM. Planta Med. 1991;57:153–155. doi: 10.1055/s-2006-960053. [DOI] [PubMed] [Google Scholar]
  • 8.Kang SS, Woo WS. Arch. Pharm. Res. 1986;9:11–13. doi: 10.1007/BF02857699. [DOI] [Google Scholar]
  • 9.Jackson GE, Campbell WE, Davidowitz B. Spectrosc. Lett. 1990;23:971–982. doi: 10.1080/00387019008054474. [DOI] [Google Scholar]
  • 10.Yang TH, Lu ST, Wang SJ, Wang TW, Lin JH, Chen IS. Yakugaku Zasshi. 1971;91:782–786. doi: 10.1248/yakushi1947.91.7_782. [DOI] [PubMed] [Google Scholar]
  • 11.Muyard F, Bevalot F, Laude B, Vaquett J. Phytochemistry. 1992;31:1087–1089. doi: 10.1016/0031-9422(92)80236-8. [DOI] [Google Scholar]
  • 12.Valesi AG, Rodriguez E, Velde GV, Mabry TJ. Phytochemistry. 1972;11:2821–2826. doi: 10.1016/S0031-9422(00)86519-X. [DOI] [Google Scholar]
  • 13.Shenghua Z, Youheng G, Zhixiong W, Rui X. Zhongcaoyao. 2011;42:1891–1893. [Google Scholar]
  • 14.Li SG, Tian HY, Ye WC, Jiang RW. Biochem. Syst. Ecol. 2011;39:64–67. doi: 10.1016/j.bse.2011.01.005. [DOI] [Google Scholar]
  • 15.Fauvel MT, Gleye J, Moulis C, Blasco F, Stanislas E. Phytochemistry. 1981;20:2059–2060. doi: 10.1016/0031-9422(81)84078-2. [DOI] [Google Scholar]
  • 16.Tsai IL, Wu SJ, Ishikawa T, Seki H, Yan ST, Chen IS. Phytochemistry. 1995;40:1562. [Google Scholar]
  • 17.Simonsen HT, Larsen MD, Nielsen MW, Adsersen A, Olsen CE, Strasberg D, Smitt UW, Jaroszewski JW. Phytochemistry. 2002;60:817–820. doi: 10.1016/S0031-9422(02)00083-3. [DOI] [PubMed] [Google Scholar]
  • 18.Basco LK, Mitaku S, Skaltsounis AL, Ravelomanantsoa N, Tillequin F, Koch M, Le Bras J. Antimicrob. Agents Chemother. 1994;38:1169–1171. doi: 10.1128/AAC.38.5.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bennett TN, Paguio M, Gligorijevic B, Kosar AA, Davidson E, Roepe PD. Antimicrob. Agents Chemother. 2004;48:1807–1810. doi: 10.1128/AAC.48.5.1807-1810.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Addo EM, Chai HB, Hymete A, Yeshak MY, Slebodnick C, Kingston DGI, Rakotondraibe LH. J. Nat. Prod. 2015;78:827–835. doi: 10.1021/np501062f. [DOI] [PubMed] [Google Scholar]

Articles from Natural Products and Bioprospecting are provided here courtesy of Springer

RESOURCES